Skip to content
Last sale
Nov 12, 2026 · -5.18%
Market cap
$1.46B
312.02M shares
Filings
304
$586.32M
FY 2025+19.7% FY25 yoy
$27.92M
FY 2025N/M FY25 yoy
$78.21M
FY 2025+12.3% FY25 yoy
-$114.67M
FY 2025derivedN/M FY25 yoy
$0.10
FY 2025N/M FY25 yoy
$172.36M
FY 2025+235.1% FY25 yoy
$1.46B
52.2×
2.5×
—
-7.87%
0.00%

FY2025 figures · derived

Price

$4.6716.31%$0.91past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$586.32MFY 2025
$586.32M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$586,321,000reported
FY 20242024-12-31$489,682,000reported
FY 20232023-12-31$91,434,000reported
FY 20222022-12-31$83,029,000reported
FY 20212021-12-31$36,772,000reported
FY 20202020-12-31$66,616,000reported

Capital returns

Dividends and buybacks · FY2020 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$0.00—$0.00—312.02M sh+3.4%—
FY2024$0.00—$0.00—301.81M sh+13.1%—
FY2023$0.00—$0.00—266.82M sh+7.3%—
FY2022$0.00—$0.00—248.65M sh——
FY2021$0.00—$0.00————

Biological products, except diagnostic substances

Alvotech is the 13th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Alvotech · CIK 1898416 · Engraved from SEC EDGAR